Patient P-02530
Therapy response
Favorable
Tolerance
Stable
GI state
Improving
Inflammatory state
Unstable
Nutritional resilience
Unstable
Discontinuation risk
55%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S07
- Day 109 Trajectory diverged from prediction — Observed response fell below the model's expected path.
What changed?
Trajectory began diverging from predicted response on Day 109.
Primary contributors, last 14 days
- GI instability-14
- Nutritional resilience+3
- Toxicity+3
- Inflammatory activity-2
What helped?
No interventions yet.
LIFE OS recommendation
GI Support Protocol GI-04
68%
probability of meaningful tolerance improvement
- 284 similar trajectories
- 89% showed improvement
- median effect visible after 8 days
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Butyrate / short-chain fatty acid production ↓80
- MicrobiomeButyrate capacity 33/100
- MicrobiomeF. prausnitzii depleted
- Daily logFibre intake low in recent food logs
- Inflammatory signalling ↓60
- MicrobiomeBacteroides fragilis expansion
- BloodInflammatory load index 58
- WearableHRV 24 ms, trending down
- Autonomic recovery ↑25
- WearableResting HR 76 bpm
- Mucosal barrier integrity ↓20
- Daily logGI symptom score 54 and rising
- Drug metabolism and exposure ↑20
- BloodToxicity index 58
DNA
Fictional pharmacogenomic panel
- CYP2D6 Intermediate metabolizerExpected exposure
- GLP1R rs6923761 AAltered receptor sensitivity
- MTHFR C677TReduced folate turnover
Microbiome
Shannon diversity 3.2 · butyrate capacity 33/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiLow
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 23 ms
- Sleep
- 6.5 h
- Steps
- 6,180
- Resting HR
- 79 bpm
Daily log: GI score 54, nutritional resilience 36, adherence 70.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
- Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
- Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Track each bowel movement today: time, stool form, urgency, overnight waking
- A 15-minute walk after lunch
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- Electrolyte solution, one sachet after any loose stool
- Fictional demo item: oral nutrition supplement with lunch
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02265 | 57% | S07 | GI-04 | no change | 67 |
| P-02334 | 53% | S04 | GI-04 | improved | 66 |
| P-02433 | 49% | S07 | GI-04 | improved | 61 |
| P-02084 | 48% | S11 | GI-04 | no change | 58 |
| P-02591 | 48% | S13 | — | — | 68 |
| P-02136 | 46% | S10 | — | — | 63 |
| P-02631 | 46% | S17 | — | — | 58 |
| P-02009 | 43% | S08 | CR-01 | improved | 64 |
| P-02029 | 43% | S18 | — | — | 56 |
| P-02046 | 43% | S10 | — | — | 55 |
| P-02054 | 43% | S01 | CR-01 | improved | 57 |
| P-02595 | 43% | S02 | — | — | 53 |